Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Researchers find genetic 'fingerprints' of ancient migrations in modern-day United Arab Emirates A team of geneticists and archaeologists have analysed the fine-scale genetic structure and ancestry of nearly 1,200 people from the United Arab Emirates (UAE), and found genetic traces of population mixing spanning thousands of years.
25 August 2021 Recent COVID-19 infection puts surgical patients at higher blood clot risk Surgical patients who have recently had COVID-19 are more likely to develop potentially fatal post-operative blood clots, a new global study reveals.
24 August 2021 Study shows low or undetectable immune response to double COVID-19 vaccination in patients with impaired immune systems A significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions mount a low or undetectable immune response after two doses of the same COVID-19 vaccine
18 August 2021 Birmingham researchers confirm speed, simplicity and sensitivity for new COVID-19 test Researchers from the University of Birmingham have confirmed the speed, accuracy and simplicity of a novel, highly sensitive testing method for COVID-19.
10 August 2021 Patients who isolate before surgery are 20% more likely to develop post-operative lung complications, finds study Patients isolating before surgery - mainly to avoid COVID-19 and its complications – are at a 20% increased risk of developing post-operative lung complications compared with patients who do not isolate.
05 August 2021 Genetic study reveals ancient human adaptation to agriculture and climate change in Middle East The most comprehensive study so far of genetic diversity in the Middle East has given a glimpse into the lives of ancient humans who lived through seismic events including the formation of the Arabian Desert.
04 August 2021 World-first UK trial to assess whether cannabis-based drug could extend life for thousands with aggressive brain tumours The University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
29 July 2021 Birmingham cancer project enters Immuno-oncology Alliance Birmingham researchers partnered with Cancer Research UK in one of the first target identification projects for the Immuno-oncology Alliance, which translates discovery science into new therapeutics for cancer patients.
13 July 2021 Partnership will create the next generation of researchers to transform global healthcare The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
13 July 2021 University of Birmingham researcher receives award for outstanding contribution to brain tumour research A researcher at the University of Birmingham has been named Young Investigator of the Year by the British Neuro-Oncology Society.
09 July 2021 COVID:19: Scientists condemn government's 'dangerous & unethical COVID-19 experiment' University of Birmingham scientists are among more than 100 experts who have signed a letter published in The Lancet urging the UK Government to reconsider its plans to abandon all COVID-19 restrictions.
29 June 2021 Blood cancer trial sponsored by the University of Birmingham opens for recruitment A new clinical trial being sponsored by the University of Birmingham has opened for recruitment aiming to investigate the efficacy of a novel treatment for patients affected by a specific type of blood cancer.
25 June 2021 Dr Lennard Lee awarded ACP McElwain Prize for contributions to medical oncology Dr Lennard Lee, Academic Clinical Lecturer at the University of Oxford/Honorary Research Fellow at the University of Birmingham, has been awarded the 2020 Association of Cancer Physicians (ACP) McElwain Prize.